Regulatory Insights and Guidelines

Stay updated on regional and global regulatory shifts impacting early-phase clinical development and generic drug registrations

EAC MRH Framework Guide

Navigating joint scientific assessments and leveraging single-study BA/BE datasets for multi-country approvals across the East African Community

ICH M10 Compliance Checklist 

Key considerations for bioanalytical method validation and study sample analysis in regulated drug development

WHO Prequalification Dossier Preparation 

Best practices for authoring clinical summaries to meet global health standards

Pharmacy and Poisons Board (PPB) Regulatory Pathways 

Practical considerations for clinical trial authorization, EC/IRB approvals, and local compliance in Kenya

Technical Whitepapers and Scientific Briefs

In-depth technical analyses from our biopharmaceutics, bioanalytical, and clinical pharmacology teams

Standard Operating Procedures (SOPs)

A robust matrix of validated, regularly reviewed SOPs governing all clinical, bioanalytical, data management, and QA activities

CAPA & Deviation Management

A structured Corrective and Preventive Action (CAPA) framework ensuring root-cause analysis, risk mitigation, and continuous process optimization

Personnel Qualification & LMS

Ongoing training programs managed through a validated Learning Management System, ensuring every investigator and analyst is qualified for assigned protocols

Change Control & Vendor Management

Rigorous evaluation processes for procedural changes, system updates, and third-party supplier qualifications

Case Studies & Development Roadmaps

Real-world applications of how our integrated clinical, bioanalytical, and consulting strategies accelerate market access

Accelerating Regional Launch via EAC Harmonization

How a generic manufacturer utilized a single pivotal BA/BE study in Nairobi to gain concurrent approval across three African markets

Successful BCS Class III Biowaiver Justification 

Eliminating human clinical trial requirements for an essential anti-infective formulation using comparative in vitro profiling

Rapid LC-MS/MS Method Development for Highly Variable APIs 

Resolving extraction recovery and stability issues within an accelerated four-week validation timeline

Webinars, FAQs & Educational Resources

Webinar Series (On-Demand)

Fundamentals of Clinical Pharmacology Units (CPUs), GCP Auditing Essentials and Pharmacokinetic Modeling with Phoenix WinNonlin

BA/BE Glossary & FAQs

A quick-reference encyclopedia defining critical terminology—from AUC0-∞, Cmax and Tmax to ALCOA+ data integrity and 90% confidence intervals (80% - 125%)

Volunteer Safety & Ethics Factsheet

Understanding the ethical framework, informed consent processes and health monitoring systems safeguarding clinical research participants